Navigation Links
Clemson bioengineer wins prestigious Early Career Award
Date:8/15/2008

CLEMSON Ning Zhang, assistant professor of bioengineering at Clemson University and the CU-MUSC Bioengineering Program, has received the prestigious 2008 Early Career Translational Research Award from the Wallace H. Coulter Foundation.

The foundation judged Zhang's research on an injectable hydrogel-based system for the treatment of stroke to be a highly promising technology that can progress towards commercial development and clinical practice. Zhang proposed the injectable hydrogel system to assist stem cell therapy for stroke treatment.

"This award exemplifies the strong leadership of Dr. Zhang in translational biomaterials research based on outstanding basic science," said Martine LaBerge, chair of Clemson's bioengineering department. "Our goal as bioengineers is to get potential life-saving treatments such as this from the research lab to the patient in an expedient manner."

The Early Career Translational Research Awards support biomedical engineering research that is translational in nature and encourage and assist eligible biomedical engineering investigators as they establish themselves in academic research careers with two years of funding.

Zhang's research on neurobioengineering has also been recognized by the 2007 Department of Defense Post-Traumatic Stress Disorder/Traumatic Brain Injury Research Program of the Office of the Congressionally Directed Medical Research Programs (CDMRP) with a Concept Award on "Brain Tissue Regeneration After Traumatic Brain Injury."

The Wallace H. Coulter Foundation is a private, nonprofit foundation in Miami dedicated to improving human healthcare by supporting translational research in biomedical engineering. Recipients of the Early Career Translational Research Awards are full-time, tenure-track faculty members with a primary appointment in biomedical engineering. They have received their doctoral degree no more than six years prior to their application, and they held a rank no higher than assistant professor at the time of application.

Wallace H. Coulter was an engineer, inventor and entrepreneur who applied engineering principles to biomedical problems. He founded Coulter Corp., which developed and marketed the first automated blood cell counters and flow cytometers, instruments that revolutionized healthcare diagnostics and therapeutics. Believing that the contributions of engineers to solving biomedical problems were generally under-recognized, Coulter mentored and encouraged young engineers to dream, take risks and be innovative.


'/>"/>
Contact: Martine LaBerge
laberge@clemson.edu
864-656-5557
Clemson University
Source:Eurekalert

Related biology news :

1. NIH recognizes Clemson nanotechnology for molecule tracking
2. Clemson physicist addresses international forum on thermoelectric energy
3. Clemson scientists shed light on molecules in living cells
4. Clemson chemists discover new way antioxidants fight debilitating diseases
5. UC Riverside bioengineer receives high honor from chemical engineers
6. Brown hosts regional bioengineering conference
7. From stem cells to organs: The bioengineering challenge
8. UCSD bioengineering grad student wins leadership award
9. Cystic fibrosis patients may breathe easier, thanks to bioengineered antimicrobials
10. Bioengineers at University of Pennsylvania devise nanoscale system to measure cellular forces
11. Springer editor Toshisada Nishida winner of 2 prestigious primatology awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
(Date:2/9/2017)... Feb. 9, 2017 The biomass boiler market ... the biomass boiler market globally in terms of revenue ... boilers. The market for biomass boilers has been segmented ... application, and country/region. The market based on feedstock type, ... residues, biogas & energy crops, urban residues, and others. ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... , March 27, 2017  The global ... for 2016, according to a new report from ... lab testing is performed to evaluate disease progression, ... therapy, among other reasons.  The healthcare market research ... , provides an overview of the medical ...
(Date:3/27/2017)... MA (PRWEB) , ... March 27, 2017 , ... ... a method to engineer scalable and customizable vascular grafts in JoVE’s Video Journal, ... may lead to new and improved ways of treating coronary artery disease (CAD). ...
(Date:3/24/2017)... MiMedx Group, Inc. (NASDAQ: MDXG), the leading ... allografts and patent-protected processes to develop and market advanced ... today  that it will present at the Needham Healthcare ... Parker H. "Pete" Petit, Chairman and CEO, Michael ... Cashman , EVP and Chief Commercialization Officer, and ...
(Date:3/24/2017)... March 24, 2017 On Thursday, ... session at 5,817.69, down 0.07%; the Dow Jones Industrial ... the S&P 500 closed at 2,345.96, marginally dropping 0.11%. ... closed in green, 4 sectors finished in red, and ... Stock-Callers.com has initiated reports coverage on the following Biotechnology ...
Breaking Biology Technology: